SCHEMBL4906129

SCHEMBL4906129

CCN(c1ccc2oc(-c3ccccc3)nc2c1)S(=O)(=O)c1ccc(C(C)C)c(C(=O)OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 9/20 0.46
PTPN5 P54829 9/20 0.46
PTPN2 P17706 8/20 0.46
HDAC6 Q9UBN7 2/20 0.43
CYP1A2 P05177 2/20 0.43
AHR P35869 1/20 0.43
UTRN P46939 1/20 0.43
HSPD1 P10809 3/20 0.43
HSPE1 P61604 3/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
CETP P11597 1/20 0.41
ALDH1A1 P00352 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895950 0.93 LMNA (0.48) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4905178 0.91 PTPN1 (0.47) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4897744 0.91 PTPN1 (0.49) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4912012 0.86 PTPN1 (0.46) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4904660 0.84 LMNA (0.49) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4903801 0.84 LMNA (0.49) PTPN1PTPN5PTPN2HDAC6CYP1A2
SCHEMBL4905062 0.82 ALDH1A1 (0.42) PKMLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL4904190 0.81 NPC1 (0.46) HDAC6PKMLMNANPC1RAB9A
SCHEMBL4895610 0.80 ALDH1A1 (0.41) PKMLMNANPC1RAB9AMEN1
SCHEMBL4909040 0.80 LMNA (0.44) PTPN1PTPN5PTPN2HDAC6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PTPN1 1702/4885PTPN5 1700/4885PTPN2 2168/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PTPN1 2340/4885PTPN5 2304/4885PTPN2 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.